Innova Captab Ltd vs Kilitch Drugs India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 19, 2026

Key Highlights

The Latest Trading Price of Innova Captab Ltd is ₹ 880.1 as of 19 May 12:42 . The P/E Ratio of Innova Captab Ltd changed from 27.2 on March 2024 to 39.2 on March 2025 . This represents a CAGR of 20.05% over 2 yearsThe P/E Ratio of Kilitch Drugs (India) Ltd changed from 34.2 on March 2021 to 21.8 on March 2025 . This represents a CAGR of -8.61% over 5 years The Market Cap of Innova Captab Ltd changed from ₹ 2564 crore on March 2024 to ₹ 5021 crore on March 2025 . This represents a CAGR of 39.93% over 2 yearsThe Market Cap of Kilitch Drugs (India) Ltd changed from ₹ 125.58 crore on March 2021 to ₹ 581.3 crore on March 2025 . This represents a CAGR of 35.86% over 5 years The revenue of Innova Captab Ltd for the Mar '26 is ₹ 449.37 crore as compare to the Dec '25 revenue of ₹ 451.95 crore. This represent the decline of -0.57% The revenue of Kilitch Drugs (India) Ltd for the Mar '26 is ₹ 90.1 crore as compare to the Dec '25 revenue of ₹ 55.34 crore. This represent the growth of 62.81% The ebitda of Innova Captab Ltd for the Mar '26 is ₹ 66.66 crore as compare to the Dec '25 ebitda of ₹ 71.05 crore. This represent the decline of -6.18% The ebitda of Kilitch Drugs (India) Ltd for the Mar '26 is ₹ 22.64 crore as compare to the Dec '25 ebitda of ₹ 7.68 crore. This represent the growth of 194.79% The net profit of Innova Captab Ltd changed from ₹ 29.48 crore to ₹ 38.08 crore over 8 quarters. This represents a CAGR of 13.65% The net profit of Kilitch Drugs (India) Ltd changed from ₹ 0.11 crore to ₹ 14.88 crore over 8 quarters. This represents a CAGR of 1063.07% The Dividend Payout of Innova Captab Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kilitch Drugs (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Innova Captab Ltd

Innova Captab Limited was incorporated as Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai.
Thereafter, the name of the Company was changed from Harun Health Care Private Limited' to Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company.
Subsequently, Company got converted to a Public Company on July 12, 2018, and the name was changed to Innova Captab Limited', dated July 26, 2018. The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports.
Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business.

About Kilitch Drugs (India) Ltd

Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe.
Their extensive research efforts have led to development of comprehensive, diverse and highly complementary portfolio of medicines targeting a wide spectrum of chronic and acute treatments which includes Sterile dosages namely Injectables & Ophthalmic, Effervescent tablets & Granules, Tablets & Capsules, OTC range covering varied Nutraceuticals & Cosmetics and Medical devices. The Company is engaged in development, manufacturing and marketing of quality finished dosages.
The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia.

FAQs for the comparison of Innova Captab Ltd and Kilitch Drugs (India) Ltd

Which company has a larger market capitalization, Innova Captab Ltd or Kilitch Drugs (India) Ltd?

Market cap of Innova Captab Ltd is 5,023 Cr while Market cap of Kilitch Drugs (India) Ltd is 593 Cr

What are the key factors driving the stock performance of Innova Captab Ltd and Kilitch Drugs (India) Ltd?

The stock performance of Innova Captab Ltd and Kilitch Drugs (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Innova Captab Ltd and Kilitch Drugs (India) Ltd?

As of May 19, 2026, the Innova Captab Ltd stock price is INR ₹877.8. On the other hand, Kilitch Drugs (India) Ltd stock price is INR ₹169.65.

How do dividend payouts of Innova Captab Ltd and Kilitch Drugs (India) Ltd compare?

To compare the dividend payouts of Innova Captab Ltd and Kilitch Drugs (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.